← Evidence map

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2016

Advances in the treatment of type 2 diabetes: impact of dulaglutide.

Angela M Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2016
2017
2018
2019
2020
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27217788